Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Man Hon

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Molecules (Basel, Switzerland)|July 14, 2023
Creating a Vaccine-like Supplement against Respiratory Infection Using Recombinant <i>Bacillus subtilis</i> Spores Expressing SARS-CoV-2 Spike Protein with Natural ProductsBen Chung-Lap Chan, Peiting Li, Miranda Sin-Man Tsang, et al.
Journal of Leukocyte Biology|September 15, 2023
Adjuvant activities of immunostimulating natural products: Astragalus membranaceus (Fisch.) Bge. and Coriolus versicolor in BNT162b2 vaccination against COVID-19 infectionBen Chung-Lap Chan, Peiting Li, Miranda Sin-Man Tsang, et al.
Journal of Negative Results in Biomedicine|December 18, 2008
Host factors do not influence the colonization or infection by fluconazole resistant Candida species in hospitalized patientsYun-Liang Yang, Ming-Fang Cheng, Ya-Wen Chang, et al.
Prostate International|July 1, 2026
Asia-Pacific collaborative consensus statements on water vapor thermal therapy (Rezūm) incorporating a systematic review, a two-round Delphi survey, and a consensus meetingBrian Wai Hei Siu, Jeremy Man Hon Ho, Xeng Inn Fam, et al.
Oncology Reports|June 30, 2018
Discovery of rafoxanide as a dual CDK4/6 inhibitor for the treatment of skin cancerXinan Shi, Hongjian Li, Anhua Shi, et al.
The American Journal of Chinese Medicine|January 23, 2013
Prospective multicenter clinical trial of Chinese herbal formula JZQG (Jiangzhuoqinggan) for hypertensionXiao-Lin Tong, Feng-Mei Lian, Qiang Zhou, et al.
The Journal of Pathology|November 24, 2022
Latent membrane protein 1 and macrophage-derived TNFα synergistically activate and mobilize invadopodia to drive invasion of nasopharyngeal carcinomaWing Chung Tang, Sai Wah Tsao, Gareth E Jones, et al.
Nature Communications|March 18, 2026
A blueprint for local and distal invasion programs in glioblastomaRony Chanoch-Myers, Toshiro Hara, Alissa C Greenwald, et al.
Molecular Medicine (Cambridge, Mass.)|February 13, 2021
Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinomaYing Zhu, Kun-Bin Ke, Zhong-Kun Xia, et al.
Frontiers in Pharmacology|August 2, 2021
Discovery of a New CDK4/6 and PI3K/AKT Multiple Kinase Inhibitor Aminoquinol for the Treatment of Hepatocellular CarcinomaZhong-Kun Xia, Wei Wang, Jian-Ge Qiu, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Molecules (Basel, Switzerland)|July 14, 2023
Creating a Vaccine-like Supplement against Respiratory Infection Using Recombinant <i>Bacillus subtilis</i> Spores Expressing SARS-CoV-2 Spike Protein with Natural ProductsBen Chung-Lap Chan, Peiting Li, Miranda Sin-Man Tsang, et al.
Journal of Leukocyte Biology|September 15, 2023
Adjuvant activities of immunostimulating natural products: Astragalus membranaceus (Fisch.) Bge. and Coriolus versicolor in BNT162b2 vaccination against COVID-19 infectionBen Chung-Lap Chan, Peiting Li, Miranda Sin-Man Tsang, et al.
Journal of Negative Results in Biomedicine|December 18, 2008
Host factors do not influence the colonization or infection by fluconazole resistant Candida species in hospitalized patientsYun-Liang Yang, Ming-Fang Cheng, Ya-Wen Chang, et al.
Prostate International|July 1, 2026
Asia-Pacific collaborative consensus statements on water vapor thermal therapy (Rezūm) incorporating a systematic review, a two-round Delphi survey, and a consensus meetingBrian Wai Hei Siu, Jeremy Man Hon Ho, Xeng Inn Fam, et al.
Oncology Reports|June 30, 2018
Discovery of rafoxanide as a dual CDK4/6 inhibitor for the treatment of skin cancerXinan Shi, Hongjian Li, Anhua Shi, et al.
The American Journal of Chinese Medicine|January 23, 2013
Prospective multicenter clinical trial of Chinese herbal formula JZQG (Jiangzhuoqinggan) for hypertensionXiao-Lin Tong, Feng-Mei Lian, Qiang Zhou, et al.
The Journal of Pathology|November 24, 2022
Latent membrane protein 1 and macrophage-derived TNFα synergistically activate and mobilize invadopodia to drive invasion of nasopharyngeal carcinomaWing Chung Tang, Sai Wah Tsao, Gareth E Jones, et al.
Nature Communications|March 18, 2026
A blueprint for local and distal invasion programs in glioblastomaRony Chanoch-Myers, Toshiro Hara, Alissa C Greenwald, et al.
Molecular Medicine (Cambridge, Mass.)|February 13, 2021
Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinomaYing Zhu, Kun-Bin Ke, Zhong-Kun Xia, et al.
Frontiers in Pharmacology|August 2, 2021
Discovery of a New CDK4/6 and PI3K/AKT Multiple Kinase Inhibitor Aminoquinol for the Treatment of Hepatocellular CarcinomaZhong-Kun Xia, Wei Wang, Jian-Ge Qiu, et al.
Pageof 11